BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Concert Pharmaceuticals, Inc. (CNCE)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Concert Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
6:02 pm
Purchase		 2022-12-31 13G Concert Pharmaceuticals, Inc.
CNCE		 BIOTECHNOLOGY VALUE FUND L P 4,917,774
9.990%		 1,321,017increase
(+36.73%)		 Filing
2021-11-15
4:58 pm
Purchase		 2021-11-03 13G Concert Pharmaceuticals, Inc.
CNCE		 BIOTECHNOLOGY VALUE FUND L P 3,596,757
9.990%		 3,596,757increase
(New Position)		 Filing